drugset / Trial / NCT04939337
A Study of TH-SC01 for Treating Complex Perianal Fistula in Perianal Crohn's Disease.
Phase 1
Unknown
24 enrolled
Jinling Hospital, China
Jiangsu Topcel-KH Pharmaceutical Co., Ltd. · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to asses the efficacy and Safety of Allogeneic Umbilical Cord-derived Mesenchymal Stem Cells in the Treatment of Complex Perianal Fistula in Perianal Crohn's Disease.
Timeline
- Start
- 2020-11-12
- Primary completion
- 2024-01
- Completion
- 2024-08
Publications
- Results Thoreson R, Cullen JJ. Pathophysiology of inflammatory bowel disease: an overview. Surg Clin North Am. 2007 Jun;87(3):575-85. doi: 10.1016/j.suc.2007.03.001.
- Wei J, Zhang Y, Chen C, Feng X, Yang Z, Feng J, Jiang Q, Fu J, Xuan J, Gao H, Liao L, Wang F. Efficacy and safety of allogeneic umbilical cord-derived mesenchymal stem cells for the treatment of complex perianal fistula in Crohn's disease: a pilot study. Stem Cell Res Ther. 2023 Oct 31;14(1):311. doi: 10.1186/s13287-023-03531-0.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TH-SC01 | Cell therapy | 1.2e+08 cells | Other |